Different patterns of β-catenin expression in gastric carcinomas: Relationship with clinicopathological parameters and prognostic outcome

Histopathology

Volumn 39, Issue 2, 2001, Pages 141-149

  Grabsch, H ^a   Takeno, S ^a   Noguchi, T ^b   Hommel, G ^c   Gabbert, H E ^a   Mueller, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b OITA UNIVERSITY   (Japan)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

catenin; Carcinoma; Prognosis; Stomach

Indexed keywords

BETA CATENIN; CADHERIN; CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; STAINING; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

BETA CATENIN; CELL DIVISION; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; CYTOSKELETAL PROTEINS; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANS-ACTIVATORS;

EID: 0035572233     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01177.x     Document Type: Article

References (44)

1. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
2. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumours
3. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
4. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
5. Prognostic value of E-cadherin expression in 413 gastric carcinomas
6. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
7. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis
8. The expression of beta-catenin in non-small-cell lung cancer: A clinicopathological study
9. P-cadherin expression in breast carcinoma indicates poor survival
10. Immunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumour progression: A comparative study with CD44
11. Predictive value of nuclear β-catenin expression for the occurrence of distant metastases in rectal cancer
12. Prognostic value of cadherin-associated molecules (α, β-, and γ-catenins and p120cas) in bladder tumours
13. Expression of E-cadherin and α-, β- and γ-catenins in human bladder carcinomas: Are they good prognostic factors?
14. Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance
15. Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing α-catenin binding to the cell adhesion protein cadherin
16. Regulating cell proliferation: As easy as APC
17. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
18. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC -/- colon carcinoma
19. Identification of c-myc as a target of the APC pathway
20. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
21. Binding of GSK3 (to the APC-β-catenin complex and regulation of complex assembly
22. Stabilization of β-catenin by genetic defects in melanoma cell lines
23. Alteration of β-catenin expression in colonic epithelial cells of familial polyposis patients
24. β-catenin expression pattern in stage I and II ovarian carcinomas. Relationship with β-catenin gene mutations, clinicopathological features, and clinical outcome
25. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
26. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer
27. TNM classification of malignant tumours
28. The two histological main types of gastric carcinomas: Diffuse and so-called intestinal-type carcinoma
29. Incidence and prognostic significance of vascular invasion in 529 gastric cancer patients
30. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma
31. Nonparametric estimation from incomplete observations
32. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation
33. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma
34. β-catenin mutation in carcinoma of the uterine endometrium
35. No evidence for mutations in the α- and β-catenin genes in human gastric and breast carcinomas
36. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer
37. β-catenin is a target for the ubiquitin-proteasome pathway
38. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer
39. Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas
40. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma
41. Mechanisms in tumour invasion: Evidence from in vivo observations
42. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma